Changes in gene expression induced by aromatic amine drugs: Testing the danger hypothesis

References

• Anunciado-Koza, R. P., Zhang, J., Ukropec, J., Bajpeyi, S., Koza, R. A., Rogers, R. C., Cefalu, W. T., Mynatt, R. L., Kozak, L. P. 2011. Inactivation of the mitochondrial carrier SLC25A25 (ATP-Mg2+/Pi Transporter) reduces physical endurance and metabolic efficiency in mice. J. Biol. Chem. 286:11659–11671.
   PubMed Web of Science ®Google Scholar
• Babic, A. M., Kireeva, M. L., Kolesnikova, T. V., Lau, L. F. 1998. CYR61 a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 95:6355–6360.
   PubMed Web of Science ®Google Scholar
• Bowen, D. G., Mccaughan, G. W., Bertolino, P. 2005. Intrahepatic immunity: A tale of two sites? Trends Immunol. 26:512–517.
   PubMed Web of Science ®Google Scholar
• Chan, H. L., Stern, R. S., Arndt, K. A., Langlois, J., Jick, S. S., Jick, H., Walker, A. M. 1990. The incidence of erythema multiforme, Stevens-Jonson syndrome, and toxic epidermal necrolysis. Arch. Dermatol. 126:43–47.
   PubMed Web of Science ®Google Scholar
• Chugh, A., Ray, A., Gupta, J. B. 2003. Squalene epoxidase as hypocholesterolemic drug target revisited. Prog. Lipid Res. 42:37–50.
   PubMed Web of Science ®Google Scholar
• Coffy, S., Decaux, J., Girard, J., Keyzer, Y., Asfari, M. 2005. Identificaiton of a novel rat hepatic gene induced early by insulin, independently of glucose. Biochem. J. 385:165–171.
   PubMedGoogle Scholar
• Coleman, M. D. 2001. Dapsone-mediated agranulocytosis: Risks, possible mechanisms and prevention. Toxicology 162:53–60.
   PubMed Web of Science ®Google Scholar
• Elsheikh, A., Lavergne, S. N., Castrejon, J. L., Farrell, J., Wang, H., Sathish, J., Pichler, W. J., Park, B. K., Naisbitt, D. J. 2010. Drug antigenicity, immunogenicity, and co-stimulatory signaling: Evidence for formation of a functional antigen through immune cell metabolism. J. Immunol. 185:6448–6460.
   PubMed Web of Science ®Google Scholar
• Farrell, J., Naisbitt, D. J., Drummond, N. S., Depta, J. P., Vilar, R. J., Pirmohomed, M., Park, B. K. 2003. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J. Pharmacol. Exp. Ther. 306:229–237.
   PubMed Web of Science ®Google Scholar
• Gallucci, S., Matzinger, P. 2001. Danger signals SOS to the immune system. Curr. Opin. Immunol. 13:113–119.
   Google Scholar
• Gill, H. J., Hough, S. J., Naisbitt, D. J., Maggs, J. L., Kitteringham, N. R., Pirmohamed, M., Park, B. K. 1997. The relationship between the disposition and immunogenicity of sulfamethoazole in the rat. J. Pharmacol. Exp. Ther. 282:795–801.
   PubMed Web of Science ®Google Scholar
• Goodman, L. S., Gilman, A., Brunton, L. L., Lazo, J. D., Parker, K. L. (Eds.). 2006. Goodman and Gilman′s the Pharmacological Basis of Therapeutics. New York: McGraw-Hill.
   Google Scholar
• Grusch, M., Drucker, C., Petervorosmarty, B., Erlach, N., Lackner, A., Losert, A., Macheiner, D., Schneider, W., Hermann, M., Groome, N. 2006. De-regulation of the activin/folli-statin system in hepatocarcinogenesis. J. Hepatol. 45:673–680.
   PubMed Web of Science ®Google Scholar
• Helton, D. R., Osborne, D. W., Pierson, S. K., Buonarati, M. H., Bethem, R. A. 2000. Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone. Drug Metab. Dispos. 28:925–929.
   PubMed Web of Science ®Google Scholar
• Khan, F. D., Vyas, P. M., Gaspari, A. A., Svensson, C. K. 2007. Effect of arylhydroxylamine metbaolites of sulfamethoxazole and dapsone on stress signal expression in human keratinocytes. J. Pharmacol. Exp. Ther. 323:771–777.
   PubMedGoogle Scholar
• Lada, A. T., Davis, M., Kent, C., Chapman, J., Tomoda, H., Omura, S., Rudel, L. L. 2003. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: Individual ACAT uniqueness. J. Lipid Res. 45:378–386.
   PubMedGoogle Scholar
• Leppa, S., Bohmann, D. 1999. Diverse function of JNK singaling and c-Jun in stress response and apoptosis. Oncogene 18:6158–6162.
   PubMedGoogle Scholar
• Li, J., Uetrecht, J. 2010. The Danger Hypothesis applied to idiosyncratic drug reactions. In: Adverse Drug Reactions (Uetrecht, J., Ed.).Berlin: Springer-Verlag, pp. 473–509.
   Google Scholar
• Lonning, P. E., Schanche, J. S., Kvinnsland, S., Ueland, P. M. 1985. Single-dose and steady-state pharmacokinetics of aminoglutethimide. Clin. Pharmacokinet. 10:353–364.
   PubMedGoogle Scholar
• Lu, W., Li, X., Uetrecht, J. P. 2008. Changes in gene expression induced by carbamazepine and phenytoin: Testing the Danger Hypothesis. J. Immunotoxicol. 5:107–113.
   PubMed Web of Science ®Google Scholar
• Machado, F. S., Johndrow, J. E., Esper, L., Dias, A., Bafica, A., Serhan, C. N., Aliberti, J. 2006. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nature Med. 12:330–334.
   PubMed Web of Science ®Google Scholar
• Matzinger, P. 1994. Tolerance, danger, and the extended family. Ann. Rev. Immunol. 12:991–1045.
   PubMed Web of Science ®Google Scholar
• Mockenhaupt, M. 2011. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev. Clin. Immunol. 7:803–815.
   PubMed Web of Science ®Google Scholar
• Mustacich, D., Powis, G. 2000. Thioredoxin reductase. Biochem. J. 346:1–8.
   PubMed Web of Science ®Google Scholar
• Nagel, G. A., Wander, H. E., Blossey, H. C. 1982. Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. Cancer Res. (Suppl.) 42:3442s–3444s.
   Web of Science ®Google Scholar
• Naisbitt, D. J., Hough, S. J., Gill, H. J., Pirmohamed, M., Kitteringham, N. R., Park, B. K. 1999. Cellular disposition of sulphamethoxazole and its metabolites: Implications for hyper-sensitivity. Br. J. Pharmacol. 126:1393–1407.
   PubMed Web of Science ®Google Scholar
• Nguyen, T., Nioi, P., Pickett, C. B. 2009. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284:13291–13295.
   PubMed Web of Science ®Google Scholar
• Nicholls, P. J., Dalrymple, P. D., Eweiss, N., Douglas, J. S. 1984. Aminoglutethimide: Absorption, physiological disposition and pharmacokinetics. In: Aminoglutethimide as an Aromatase Inhibitor in the Treatment of Cancer: An International Symposium Held During the 13th International Congress of Chemotherapy. Vienna, Austria (Nagel, G. A.Santen, R. J., Eds.). Berne, Switzerland:Hans Huber, pp. 58–67.
   Google Scholar
• Pacitto, S. R., Uetrecht, J. P., Boutros, P. C., Popovic, M. 2007. Changes in gene expression induced by tienilic acid and sulfamethoxazole: Testing the Danger Hypothesis. J. Immunotoxicol. 4:253–266.
   PubMed Web of Science ®Google Scholar
• Patterson, K. I., Brummer, T., O′brien, P. M., Daly, R. J. 2009. Dual-specificity phosphatases: Critical regulators with diverse cellular targets. Biochem. J. 418:475–489.
   PubMed Web of Science ®Google Scholar
• Roychowdhury, S., Vyas, P. M., Reilly, T. P., Gaspari, A. A., Svensson, C. K. 2005. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J. Pharmacol. Exp. Ther. 314:43–52.
   PubMed Web of Science ®Google Scholar
• Sanderson, J. P., Naisbitt, D. J., Farrell, J., Ashby, C. A., Tucker, M. J., Rieder, M. J., Pirmohamed, M., Clarke, S. E., Park, B. K. 2007. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J. Immunol. 178:5533–5542.
   PubMed Web of Science ®Google Scholar
• Schwartz, D. E., Rieder, J. 1970. Pharmacokinetics of sulfamethoxazole and trimethoprim in man and their distribution in the rat. Chemotherapy 15:337–355.
   PubMed Web of Science ®Google Scholar
• Seguin, B., Boutros, P. C., Li, X., Okey, A. B., Uetrecht, J. P. 2005. Gene expression profiling in a model of D-penicillamine-induced autoimmunity in the Brown Norway rat: Predictive value of early signs of danger. Chem. Res. Toxicol. 18:1193–1202.
   PubMed Web of Science ®Google Scholar
• Uetrecht, J. 1989. Dapsone and sulfapyridine. In: Clinics in Dermatology (Shear, N. H., Ed.).Philadelphia, PA: Lippincott, pp. 111–120.
   Google Scholar
• Uetrecht, J. 2002. N-Oxidation of drugs associated with idiosyncratic drug reactions. Drug Metab. Rev. 34:651–665.
   PubMed Web of Science ®Google Scholar
• Uetrecht, J. 2009. Immune-mediated adverse drug reactions. Chem. Res. Toxciol. 22:24–34.
   PubMed Web of Science ®Google Scholar
• Webster, M. K., Goya, L., Firestone, G. L. 1993. Immediate-early transcriptional regulation and rapid mRNA turnover of a putative serine/threonine protein kinase. J. Biol. Chem. 268:11482–11485.
   PubMed Web of Science ®Google Scholar
• Welch, C., Santra, M. K., El-Assaad, W., Zhu, X., Huber, W. E., Keys, R. A., Teodoro, J. G., Green, M. R. 2009. Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2. Cancer Res. 69:6782–6789.
   Google Scholar
• Xu, H., Bai, L., Collins, J. F., Ghishan, F. K. 1999. Molecular cloning, functional characterization, tissue distribution, and chromosomal localization of a human, small intestinal sodium-phosphate (Na+-Pi) transporter (SLC34A2). Genomics 62:281–284.
   PubMed Web of Science ®Google Scholar
• Young, J. A., Newcomer, L. N., Keller, A. M. 1984. Aminoglutethimide-induced bone marrow injury: Report of a case and review of the literature. Cancer 54:1731–1733.
   PubMedGoogle Scholar
• Zandbergen, F., Mandard, S., Escher, P., Tan, N. S., Nguan, S., Patsouris, D., Jatkoe, T., Rojas-Caro, S., Madore, S., Wahli, W., Tafuri, S., Müller, M., Kersten, S. 2005. The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem. J. 392:313–324.
   PubMed Web of Science ®Google Scholar